Professor Hannah Batchelor

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

I am currently a Professor in Pharmaceutics within the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland.

My broad research interests focus on the development of age-appropriate medicines for children. Specific research topics of interest include paediatric biopharmaceutics and development of appropriate in vitro testing strategies to predict in vivo performance; paediatric in silico modelling to optimise pharmacokinetic study design and the impact of drug-food interactions within paediatric populations. This links in silico software predictive models to better understand the mechanics of drug absorption. I am specifically interested in specialist populations (not only paediatrics) and how we can minimise the burden associated with clinical trials. This topic has generated extensive interest from large pharmaceutical companies as well as regulatory agencies and I have funding from the FDA, Janssen and Certara for ongoing projects in this space.

I am actively involved in involvement of children and young people in research, particularly clinical research that impacts upon the treatment of this population. This has led to engagement and outreach opportunities and cross-institute collaborations. I am an active member of the National Institute for Health Research (NIHR) clinical research network that involves children and young people and ensures that they are collaborators in research where possible.

I am an internationally recognised expert in the paediatric drug delivery research ranging from biopharmaceutics to acceptability assessment.

I am currently the Chair of the Academy of Pharmaceutical Sciences (www.apsgb.co.uk)

Expertise

Back to staff profile

Prize And Awards

Chair of the Academy of Pharmaceutical Sciences: Recipient; 1/1/2022

More prizes and awards

Publications

Back to staff profile

Publications

An expert’s view on the application of TIM technology in the development of oral drug products: López Mármol Álvaro, Barker Richard, Koziolek Mirko, Schwabe Robert, Hens Bart, Sarcevica Inese, Butler James M, McAllister Mark, Taylor Edward, Chiang Po-Chang, Stainforth Nick, Jones Eleanor, Batchelor Hannah; Molecular Pharmaceutics Vol 23, pp. 2219-2245 (2026); https://doi.org/10.1021/acs.molpharmaceut.5c01197
TIM-1 and Tiny-TIM as robust in vitro models for oral biopharmaceutics : evidence from an international ring study: O’Farrell Connor, Havenaar Robert, McAllister Mark, Hens Bart, Barker Richard, Mármol Álvaro López, Ansari Andrea, Ooms Tom, Schilderink Ronald, Schwabe Robert, Butler James, Stróžyk Malgorzata, Martins Garcia Tânia, Minekus Dyko, Sarcevica Inese, Smith Kieran, Tomaszewska Irena, Jones Eleanor, Batchelor Hannah, Bellmann Susann; Pharmaceutics Vol 18 (2026); https://doi.org/10.3390/pharmaceutics18040400
Global Pediatric Legislation for Pediatric Medicines in LMIC Regions: Batchelor Hannah; Pediatric Formulations AAPS Advances in the Pharmaceutical Sciences Series (2026) (2026); https://doi.org/10.1007/978-3-031-77240-5_22
Modeling and Simulation for Pediatric Formulation Development: Batchelor Hannah; Pediatric Formulations AAPS Advances in the Pharmaceutical Sciences Series (2026) (2026); https://doi.org/10.1007/978-3-031-77240-5_20
Paediatric Formulations : Nasal, Ocular and Otic Drug Delivery: Batchelor Hannah; Pediatric Formulations AAPS Advances in the Pharmaceutical Sciences Series (2026) (2026); https://doi.org/10.1007/978-3-031-77240-5_15
The Dangerous Business of Predicting the Future: Bar-Shalom Daniel, Batchelor Hannah, McElhiney Linda F, Rose Klaus; Pediatric Formulations AAPS Advances in the Pharmaceutical Sciences Series (2026) (2026); https://doi.org/10.1007/978-3-031-77240-5_24

More publications

Research

Back to staff profile

Professional Activities

Cross-Faculty Connections: Growing Networks and Building Opportunities with and for Children and Young People: Organiser; 26/2/2026
Co-designing community priorities: Organiser; 24/2/2026
Facility Showcase Event: Participant; 20/5/2025
CPU program review: Participant; 2/12/2024
Improving predictability of generic product bioequivalence in pediatric populations by using advanced dissolution apparatus in conjunction with PBPK modelling for high risk oral products: Speaker; 21/5/2024
Academy of Pharmaceutical Sciences Pharm Sci 2023: Participant; 6/9/2023

More professional activities

Projects

GI Bio Costing TIM continued work (3): Batchelor, Hannah (Principal Investigator) Jones, Eleanor (Co-investigator); 01-Jan-2025 - 31-Jan-2026
UDLA 2527 University of Strathclyde | Roy, Benjamin: Cordeiro, Sara (Principal Investigator) Batchelor, Hannah (Co-investigator) Roy, Benjamin (Research Co-investigator); 01-Jan-2025 - 01-Jan-2029
GI Bio Costing: Batchelor, Hannah (Principal Investigator) Jones, Eleanor (Co-investigator); 06-Jan-2024 - 03-Jan-2026
Revolutionising relative bioavailability testing: Using AI-PAT to Eliminate Animal Models: Batchelor, Hannah (Principal Investigator) Wilkinson, Michael (Co-investigator); 07-Jan-2024 - 06-Jan-2025
DTP 2224 University of Strathclyde | Barham, Sara: Perrie, Yvonne (Principal Investigator) Batchelor, Hannah (Co-investigator) Barham, Sara (Research Co-investigator); 01-Jan-2024 - 01-Jan-2028
Consultancy regarding Discovery, Product Development & Supply: Batchelor, Hannah (Principal Investigator); 30-Jan-2023 - 31-Jan-2025